Southern Acids (M) Bhd (5134) — Capital Reinvestment Ratio
Latest as of December 2025:
0.32x
Southern Acids (M) Bhd (5134) has a Capital Reinvestment Ratio of 0.32x as of December 2025, meaning it reinvests 0% of its operating cash flow (RM59.37 Million) in capital expenditures (RM19.13 Million). See 5134 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.32x
Capex / Operating Cash Flow
Operating Cash Flow
RM59.37 Million
MYR
Capital Expenditures
RM19.13 Million
MYR
Data as of
Dec 2025
Most recent filing
Southern Acids (M) Bhd Capital Reinvestment Ratio (2013–2025)
This chart tracks Southern Acids (M) Bhd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Southern Acids (M) Bhd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Southern Acids (M) Bhd from 2013 to 2025. For live market cap and broader valuation context, see 5134 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.75x | RM51.25 Million | RM38.58 Million | ▼ -37.8% |
| 2024 | 1.21x | RM27.98 Million | RM33.88 Million | ▲ +411.1% |
| 2023 | 0.24x | RM108.89 Million | RM25.80 Million | ▼ -1.2% |
| 2022 | 0.24x | RM85.17 Million | RM20.42 Million | ▼ -49.3% |
| 2021 | 0.47x | RM48.50 Million | RM22.96 Million | ▼ -10.9% |
| 2020 | 0.53x | RM29.80 Million | RM15.84 Million | ▼ -10.4% |
| 2019 | 0.59x | RM65.69 Million | RM38.96 Million | ▼ -3.2% |
| 2018 | 0.61x | RM56.25 Million | RM34.45 Million | ▼ -50.7% |
| 2017 | 1.24x | RM17.21 Million | RM21.37 Million | ▲ +104.3% |
| 2016 | 0.61x | RM28.91 Million | RM17.58 Million | ▼ -41.8% |
| 2015 | 1.04x | RM45.00 Million | RM47.00 Million | ▲ +63.5% |
| 2014 | 0.64x | RM36.00 Million | RM23.00 Million | ▲ +293.2% |
| 2013 | 0.16x | RM80.00 Million | RM13.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow